China National Medicines Corporation Ltd. (SHA:600511)

Market Cap	23.20B
Revenue (ttm)	51.19B
Net Income (ttm)	2.00B
Shares Out	754.50M
EPS (ttm)	2.65
PE Ratio	11.60
Forward PE	10.57
Dividend	0.80 (2.67%)
Ex-Dividend Date	Jun 13, 2024

Volume	1,110,316
Average Volume	3,866,463
Open	30.65
Previous Close	30.75
Day's Range	30.56 - 30.82
52-Week Range	27.12 - 38.00
Beta	0.56
RSI	61.23
Earnings Date	Aug 22, 2025

About SHA:600511

China National Medicines Corporation Ltd., together with its subsidiaries, distributes pharmaceutical products in China. The company also manufactures and sells new drugs and finished drugs; sells Chinese patent medicines and western medicines, and medical equipment; and offers warehousing and import and export agency services. It serves hospitals, retail pharmacies, and medical institutions. The company was founded in 1999 and is based in Beijing, China.

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1999
• Employees: 3,104
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600511

Financial Performance

In 2024, SHA:600511's revenue was 50.60 billion, an increase of 1.81% compared to the previous year's 49.70 billion. Earnings were 2.00 billion, a decrease of -6.80%.